open access

Vol 10, No 6 (2021)
Other materials agreed with the Editors
Submitted: 2021-04-09
Accepted: 2021-09-14
Published online: 2021-12-28
Get Citation

The essentials of diabetes prevention and management during COVID-19 pandemic

Israel Oluwasegun Ayenigbara1
DOI: 10.5603/DK.2021.0052
·
Clinical Diabetology 2021;10(6):429-437.
Affiliations
  1. University of Ibadan, Department of Health Education, School and Community Health Unit, University of Ibadan, Nigeria, 234 Ibadan, Nigeria

open access

Vol 10, No 6 (2021)
COVID-19 AND DIABETES
Submitted: 2021-04-09
Accepted: 2021-09-14
Published online: 2021-12-28

Abstract

Diabetes cases are soaring at alarming rates globally,

majorly type 2 diabetes, with 90% of cases while the

Africa and Asia continents will be the epicenter and

battlegrounds for the condition in the coming years.

Presently, the world is faced with a coronavirus disease

(COVID-19) pandemic, and similar to many other

diseases, diabetes shares negative associations with

COVID-19 in terms of disease severity and outcomes,

some of which are longer hospitalization, higher risk

of mortality, longer periods of recovery, higher odds

of admission into the intensive care unit (ICU), and

higher risk of severe illnesses in association with other

co-morbidities.

To this end, there is a need for an efficient diabetes

prevention and management plan that is generally

accepted among all populations worldwide during the

pandemic and afterward. In this respect, this narrative

review provides a broad overview on research detailing

effective preventive and management alternatives

against diabetes, and findings affirmed that engaging

in regular physical activities, adequate intake of dietary

fiber, intake of total plant foods, quitting and avoiding

smoking, maintaining a healthy weight, avoiding the

intake of alcohol, avoiding fats and sugary laden diets,

avoiding drugs and medications that cause diabetes,

controlling blood pressure and cardiovascular diseases,

infection prevention, regular medical checkup and

screening, and prevention of depression and stress will

offer beneficial effects in the prevention of diabetes,

preventing the progression of diabetes among the

high-risk population, and the prevention of complications

among diabetes patients during and after the

pandemic.

Abstract

Diabetes cases are soaring at alarming rates globally,

majorly type 2 diabetes, with 90% of cases while the

Africa and Asia continents will be the epicenter and

battlegrounds for the condition in the coming years.

Presently, the world is faced with a coronavirus disease

(COVID-19) pandemic, and similar to many other

diseases, diabetes shares negative associations with

COVID-19 in terms of disease severity and outcomes,

some of which are longer hospitalization, higher risk

of mortality, longer periods of recovery, higher odds

of admission into the intensive care unit (ICU), and

higher risk of severe illnesses in association with other

co-morbidities.

To this end, there is a need for an efficient diabetes

prevention and management plan that is generally

accepted among all populations worldwide during the

pandemic and afterward. In this respect, this narrative

review provides a broad overview on research detailing

effective preventive and management alternatives

against diabetes, and findings affirmed that engaging

in regular physical activities, adequate intake of dietary

fiber, intake of total plant foods, quitting and avoiding

smoking, maintaining a healthy weight, avoiding the

intake of alcohol, avoiding fats and sugary laden diets,

avoiding drugs and medications that cause diabetes,

controlling blood pressure and cardiovascular diseases,

infection prevention, regular medical checkup and

screening, and prevention of depression and stress will

offer beneficial effects in the prevention of diabetes,

preventing the progression of diabetes among the

high-risk population, and the prevention of complications

among diabetes patients during and after the

pandemic.

Get Citation

Keywords

diabetes, prevention, management, SARS-COV2, COVID-19, pandemic period

About this article
Title

The essentials of diabetes prevention and management during COVID-19 pandemic

Journal

Clinical Diabetology

Issue

Vol 10, No 6 (2021)

Article type

Other materials agreed with the Editors

Pages

429-437

Published online

2021-12-28

Page views

1397

Article views/downloads

186

DOI

10.5603/DK.2021.0052

Bibliographic record

Clinical Diabetology 2021;10(6):429-437.

Keywords

diabetes
prevention
management
SARS-COV2
COVID-19
pandemic period

Authors

Israel Oluwasegun Ayenigbara

References (70)
  1. World Health Organization. Diabetes. https://www.who.int/news-room/fact-sheets/detail/diabetes (9.02.2020).
  2. International Diabetes Federation. IDF DIABETES ATLAS Ninth Edition 2019. https://www.diabetesatlas.org/upload/resources/material/20200302_133351_IDFATLAS9e-final-web.pdf (8.02.2020).
  3. John E. Diabetics worldwide 2019 and 2045. https://www.statista.com/statistics/271442/number-of-diabetics-worldwide/ (8.02.2019).
  4. Shi Y, Hu FB. The global implications of diabetes and cancer. Lancet. 2014; 383(9933): 1947–1948.
  5. World Health Organization. Global Report on Diabetes. https://apps.who.int/iris/bitstream/10665/204871/1/9789241565257_eng.pdf&sa=U&ved=2ahUKEwjtqIW-pOjsAhUJ6aQKHZYhBqUQFjAAegQIBBAB&usg=AOvVaw2dIq0L_Xe4wEd-yqDPO11v (8.02.2020).
  6. Melmed S, Larsen PR, Kronenberg H. Williams textbook of endocrinology (12th ed.). Elsevier/Saunders. 2011: 1371–1435.
  7. Vos T, Flaxman AD, Naghavi M, et al. Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012; 380(9859): 2163–2196.
  8. Gale E, Gillespie KM. Diabetes and gender. Diabetologia. 2001; 44(1): 3–15.
  9. Meisinger C, Thorand B, Schneider A, et al. Sex differences in risk factors for incident type 2 diabetes mellitus: the MONICA Augsburg cohort study. Arch Intern Med. 2002; 162(1): 82–89.
  10. Public Health Agency of Canada, Diabetes in Canada: Facts and figures from a public health perspective. Ottawa, 2011. https://www.canada.ca/content/dam/phac-aspc/migration/phac-aspc/cd-mc/publications/diabetes-diabete/facts-figures-faits-chiffres-2011/pdf/facts-figures-faits-chiffres-eng.pdf (8.02.2020).
  11. Mathers CD, Loncar D. Projections of global mortality and burden of disease from 2002 to 2030. PLoS Med. 2006; 3(11): e442.
  12. Wild S, Roglic G, Green A, et al. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care. 2004; 27(5): 1047–1053.
  13. American Diabetes Association. Economic Costs of Diabetes in the U.S. in 2017. Diabetes Care. 2018; 41(5): 917–928.
  14. Center for Disease Control and Prevention. Deaths and Cost | Data & Statistics | Diabetes . https://www.cdc.gov/nchs/nvss/deaths.htm (8.02.2020).
  15. Ayenigbara IO. COVID-19: An International Public Health Concern. Cent Asian J Glob Health. 2020; 9(1): e466.
  16. Center for Disease Control and Prevention. COVID-19. Clinical Care Guidance. [Internet]. 2020. https://www.cdc.gov/coronavirus/2019-ncov/hcp/clinical-guidance-management-patients.html (8.02.2020).
  17. Miller LE, Bhattacharyya R, Miller AL. Diabetes mellitus increases the risk of hospital mortality in patients with Covid-19: Systematic review with meta-analysis. Medicine (Baltimore). 2020; 99(40): e22439.
  18. Aggarwal G, Lippi G, Lavie CJ, et al. Diabetes mellitus association with coronavirus disease 2019 (COVID-19) severity and mortality: A pooled analysis. J Diabetes. 2020; 12(11): 851–855.
  19. Ceriello A, Standl E, Catrinoiu D, et al. “Diabetes and Cardiovascular Disease (D&CVD)” Study Group of the European Association for the Study of Diabetes (EASD). Issues for the management of people with diabetes and COVID-19 in ICU. Cardiovasc Diabetol. 2020; 19(1): 114.
  20. Nandy K, Salunke A, Pathak SK, et al. Coronavirus disease (COVID-19): A systematic review and meta-analysis to evaluate the impact of various comorbidities on serious events. Diabetes Metab Syndr. 2020; 14(5): 1017–1025.
  21. Bello-Chavolla OY, Bahena-López JP, Antonio-Villa NE, et al. Predicting Mortality Due to SARS-CoV-2: A Mechanistic Score Relating Obesity and Diabetes to COVID-19 Outcomes in Mexico. J Clin Endocrinol Metab. 2020; 105(8).
  22. International Diabetes Federation. COVID-19 and Diabetes. [Internet]. 2021. https://www.idf.org/aboutdiabetes/what-is-diabetes/covid-19-and-diabetes/1-covid-19-and-diabetes.html (8.02.2020).
  23. Aune D, Norat T, Leitzmann M, et al. Physical activity and the risk of type 2 diabetes: a systematic review and dose-response meta-analysis. Eur J Epidemiol. 2015; 30(7): 529–542.
  24. Francesconi C, Niebauer J, Haber P, et al. [Physical activity and exercise training in the prevention and therapy of type 2 diabetes mellitus]. Wien Klin Wochenschr. 2016; 128 Suppl 2(Suppl 1): S141–S145.
  25. Lumb A. Diabetes and exercise. Clin Med (Lond). 2014; 14(6): 673–676.
  26. Aune D, Sen A, Henriksen T, et al. Physical activity and the risk of gestational diabetes mellitus: a systematic review and dose-response meta-analysis of epidemiological studies. Eur J Epidemiol. 2016; 31(10): 967–997.
  27. Di Biase N, Balducci S, Lencioni C, et al. Review of general suggestions on physical activity to prevent and treat gestational and pre-existing diabetes during pregnancy and in postpartum. Nutr Metab Cardiovasc Dis. 2019; 29(2): 115–126.
  28. Weickert MO, Pfeiffer AFH. Impact of Dietary Fiber Consumption on Insulin Resistance and the Prevention of Type 2 Diabetes. J Nutr. 2018; 148(1): 7–12.
  29. Sylvetsky AC, Edelstein SL, Walford G, et al. Diabetes Prevention Program Research Group. A High-Carbohydrate, High-Fiber, Low-Fat Diet Results in Weight Loss among Adults at High Risk of Type 2 Diabetes. J Nutr. 2017; 147(11): 2060–2066.
  30. Weickert MO. High fiber intake, dietary protein, and prevention of type 2 diabetes. Expert Rev Endocrinol Metab. 2018; 13: 223-224.
  31. Dahl WJ, Stewart ML. Position of the Academy of Nutrition and Dietetics: Health Implications of Dietary Fiber. J Acad Nutr Diet. 2015; 115(11): 1861–1870.
  32. Joshi S, McMacken M, Kalantar-Zadeh K, et al. A plant-based diet for the prevention and treatment of type 2 diabetes. J Geriatr Cardiol. 2017; 14(5): 342–354.
  33. Schwingshackl L, Hoffmann G, Lampousi AM, et al. Food groups and risk of type 2 diabetes mellitus: a systematic review and meta-analysis of prospective studies. Eur J Epidemiol. 2017; 32(5): 363–375.
  34. Olfert MD, Wattick RA. Vegetarian Diets and the Risk of Diabetes. Curr Diab Rep. 2018; 18(11): 101.
  35. Palacios OM, Kramer M, Maki KC. Diet and prevention of type 2 diabetes mellitus: beyond weight loss and exercise. Expert Rev Endocrinol Metab. 2019; 14(1): 1–12.
  36. Brath H, Kaser S, Tatschl C, et al. [Smoking, alcohol and diabetes (Update 2019)]. Wien Klin Wochenschr. 2019; 131(Suppl 1): 67–70.
  37. Śliwińska-Mossoń M, Milnerowicz H. The impact of smoking on the development of diabetes and its complications. Diab Vasc Dis Res. 2017; 14(4): 265–276.
  38. Zhu P, Pan XF, Sheng L, et al. Cigarette Smoking, Diabetes, and Diabetes Complications: Call for Urgent Action. Curr Diab Rep. 2017; 17(9): 78.
  39. Akter S, Goto A, Mizoue T. Smoking and the risk of type 2 diabetes in Japan: A systematic review and meta-analysis. J Epidemiol. 2017; 27(12): 553–561.
  40. Lau DCW, Teoh H. Current and Emerging Pharmacotherapies for Weight Management in Prediabetes and Diabetes. Can J Diabetes. 2015; 39 Suppl 5: S134–S141.
  41. Grams J, Garvey WT. Weight Loss and the Prevention and Treatment of Type 2 Diabetes Using Lifestyle Therapy, Pharmacotherapy, and Bariatric Surgery: Mechanisms of Action. Curr Obes Rep. 2015; 4(2): 287–302.
  42. Rhee EJ, Cho JH, Kwon H, et al. Increased risk of diabetes development in individuals with weight cycling over 4 years: The Kangbuk Samsung Health study. Diabetes Res Clin Pract. 2018; 139: 230–238.
  43. Bollyky JB, Bravata D, Yang J, et al. Remote Lifestyle Coaching Plus a Connected Glucose Meter with Certified Diabetes Educator Support Improves Glucose and Weight Loss for People with Type 2 Diabetes. J Diabetes Res. 2018; 2018: 3961730.
  44. Lai YJ, Hu HY, Lee YL, et al. Frequency of alcohol consumption and risk of type 2 diabetes mellitus: A nationwide cohort study. Clin Nutr. 2019; 38(3): 1368–1372.
  45. Peng M, Zhang J, Zeng T, et al. Alcohol consumption and diabetes risk in a Chinese population: a Mendelian randomization analysis. Addiction. 2019; 114(3): 436–449.
  46. Polsky S, Akturk HK. Alcohol Consumption, Diabetes Risk, and Cardiovascular Disease Within Diabetes. Curr Diab Rep. 2017; 17(12): 136.
  47. MacNaught N, Holt P. Type 1 diabetes and alcohol consumption. Nurs Stand. 2015; 29(50): 41–47.
  48. Rice Bradley BH. Dietary Fat and Risk for Type 2 Diabetes: a Review of Recent Research. Curr Nutr Rep. 2018; 7(4): 214–226.
  49. Popov D, Simionescu M, Shepherd PR. Saturated-fat diet induces moderate diabetes and severe glomerulosclerosis in hamsters. Diabetologia. 2003; 46(10): 1408–1418.
  50. Carrasquilla GD, Jakupović H, Kilpeläinen TO. Dietary Fat and the Genetic Risk of Type 2 Diabetes. Curr Diab Rep. 2019; 19: 109.
  51. Gijsbers L, Ding EL, Malik VS, et al. Consumption of dairy foods and diabetes incidence: a dose-response meta-analysis of observational studies. Am J Clin Nutr. 2016; 103(4): 1111–1124.
  52. Diabetes.co.uk. Drug Induced Diabetes. [Internet]. 2020. https://www.diabetes.co.uk/drug-induced-diabetes.html (8.02.2020).
  53. Aroda VR, Knowler WC, Crandall JP, et al. Diabetes Prevention Program Research Group. Metformin for diabetes prevention: insights gained from the Diabetes Prevention Program/Diabetes Prevention Program Outcomes Study. Diabetologia. 2017; 60(9): 1601–1611.
  54. Chiasson JL, Josse RG, Gomis R, et al. STOP-NIDDM Trail Research Group. Acarbose for prevention of type 2 diabetes mellitus: the STOP-NIDDM randomised trial. Lancet. 2002; 359(9323): 2072–2077.
  55. Strain WD, Paldánius PM. Diabetes, cardiovascular disease and the microcirculation. Cardiovasc Diabetol. 2018; 17(1): 57.
  56. Vargas-Uricoechea H, Cáceres-Acosta MF. Blood pressure control and impact on cardiovascular events in patients with type 2 diabetes mellitus: A critical analysis of the literature. Clin Investig Arterioscler. 2019; 31(1): 31–47.
  57. Ferrannini E, Cushman WC. Diabetes and hypertension: the bad companions. Lancet. 2012; 380(9841): 601–610.
  58. Chakraborty S, Bhattacharyya R, Banerjee D. Infections: A Possible Risk Factor for Type 2 Diabetes. Adv Clin Chem. 2017; 80: 227–251.
  59. He C, Yang Z, Lu NH. Helicobacter pylori infection and diabetes: is it a myth or fact? World J Gastroenterol. 2014; 20(16): 4607–4617.
  60. Kato M, Toda A, Yamamoto-Honda R, et al. Association between Helicobacter pylori infection, eradication and diabetes mellitus. J Diabetes Investig. 2019; 10(5): 1341–1346.
  61. Martinez LC, Sherling D, Holley A. The Screening and Prevention of Diabetes Mellitus. Prim Care. 2019; 46(1): 41–52.
  62. Shealy KM, Wu J, Waites J, et al. Patterns of Diabetes Screening and Prediabetes Treatment during Office Visits in the US. J Am Board Fam Med. 2019; 32(2): 209–217.
  63. Schwarz PEH. [Screening and prevention of diabetes]. Internist (Berl). 2015; 56: 1124-33.
  64. Yu M, Zhang X, Lu F, et al. Depression and Risk for Diabetes: A Meta-Analysis. Can J Diabetes. 2015; 39(4): 266–272.
  65. Rotella F, Mannucci E, Rotella F, et al. Diabetes mellitus as a risk factor for depression. A meta-analysis of longitudinal studies. Diabetes Res Clin Pract. 2013; 99(2): 98–104.
  66. Campayo A, Gómez-Biel CH, Lobo A. Diabetes and depression. Curr Psychiatry Rep. 2011; 13(1): 26–30.
  67. Hackett RA, Steptoe A. Type 2 diabetes mellitus and psychological stress - a modifiable risk factor. Nat Rev Endocrinol. 2017; 13(9): 547–560.
  68. Sharma VK, Singh TG. Chronic Stress and Diabetes Mellitus: Interwoven Pathologies. Curr Diabetes Rev. 2020; 16(6): 546–556.
  69. Sharif K, Watad A, Coplan L, et al. Psychological stress and type 1 diabetes mellitus: what is the link? Expert Rev Clin Immunol. 2018; 14(12): 1081–1088.
  70. Thomas T, Pfeiffer AFH. Foods for the prevention of diabetes: how do they work? Diabetes Metab Res Rev. 2012; 28(1): 25–49.

Regulations

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

 

Wydawcą serwisu jest  "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail:  viamedica@viamedica.pl